南美洲和中美洲癌症疫苗市场预测至 2027 年 - COVID-19 影响和区域技术分析(树突状细胞癌症疫苗、重组癌症疫苗、抗原癌症疫苗、全细胞癌症疫苗、病毒载体癌症疫苗);类型(预防性癌症疫苗、治疗性癌症疫苗);适应症(宫颈癌、前列腺癌、其他适应症);最终用户(儿科、成人)和国家/地区

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 164    |    Report Code: TIPRE00015134    |    Category: Life Sciences

South and Central America Cancer Vaccines Market

市场介绍

这份研究报告提供了对南部和南部地区的见解。中美洲癌症疫苗市场。癌症疫苗是一种治疗现有癌症或预防癌症发展的疫苗。已建立的癌症治疗疫苗被称为治疗性癌症疫苗。一些/许多疫苗是“自体”的,由患者样本制成,并且是该患者所独有的。此外,癌症疫苗可以有两种类型:治疗性疫苗和预防性疫苗。例如,Cervarix、Gardasil、Gardasil-9 和乙型肝炎 (HBV) 疫苗 (HEPLISAV-B) 都是预防性癌症疫苗。而卡介苗 (BCG)、Sipuleucel-T (Provenge) 都是治疗性癌症疫苗

市场概况和动态

2019年南美洲和中美洲癌症疫苗市场价值为1.9189亿美元,预计到2027年将达到6.2749亿美元;预计在预测期内复合年增长率为 16.3%。推动需求增长的因素包括全球癌症患病率的上升以及 South & Co. 采取的措施。中美洲健康研究组织和癌症疫苗的主要参与者。由于供应链的延误和锁定条件,新冠肺炎疫情对该行业产生了重大影响。然而,癌症疫苗行业的问题,例如癌症疫苗价格上涨,阻碍了市场增长。

关键细分市场

从技术角度来看,2019年重组癌症疫苗细分市场占据最大份额;预计在预测期内将达到市场上最高的复合年增长率。从类型来看,预防性癌症疫苗领域在 2019 年占据了较大的市场份额,预计在预测期内也将在市场中占据更高的市场份额。同样,就最终用户而言,儿科细分市场在 2019 年占据了更大的市场份额,预计在预测期内该市场的复合年增长率将更高。

主要来源和上市公司

世界健康组织 (WHO)、食品药品监督管理局 (FDA)、疾病控制与预防中心 (CDC) 和加拿大医疗技术制造商协会联盟是南方和亚洲的一些主要的主要和次要来源。报告中包含中美洲癌症疫苗市场。

购买该报告的理由

  • 了解南方和南方中美洲癌症疫苗市场格局并确定最有可能保证强劲回报的细分市场
  • 通过了解南方和美洲不断变化的竞争格局,保持领先地位。中美洲癌症疫苗市场
  • 有效规划南美洲和北美地区的并购和合作交易通过识别最有希望的可能销售的细分市场,帮助中美洲癌症疫苗市场通过对南美洲和南美洲各个细分市场的市场表现进行敏锐和全面的分析,做出明智的业务决策。中美洲癌症疫苗市场
  • 获取该地区2019年至2027年各细分市场的市场收入预测

南和南中美洲癌症疫苗市场细分

按技术

  • Dendritic细胞癌症疫苗
  • 重组癌症疫苗
  • 抗原癌症疫苗
  • 全细胞癌症疫苗
  • 病毒载体癌症疫苗

South &中美洲癌症疫苗市场 –按

类型

  • 预防癌症疫苗
  • 治疗性癌症疫苗

南和南中美洲癌症疫苗市场 –按

适应症

  • 宫颈癌
  • 前列腺癌
  • 其他适应症

南部和南部地区中美洲癌症疫苗市场&nd;按最终用途

  • 儿科
  • 成人
  • 公司简介

    • 阿斯利康
    • 葛兰素史克plc.
    • Aduro Biotech Inc.
    • 辉瑞公司
    • 赛诺菲
    • 百时美施贵宝
    • Moderna, Inc.
    • OncBioMune Pharmaceuticals Inc.
    • MaxiVAX
    • Nouscom


    South and Central America Cancer Vaccines Strategic Insights

    Strategic insights for South and Central America Cancer Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/south-and-central-america-cancer-vaccines-market-strategic-framework.webp
    Get more information on this report

    South and Central America Cancer Vaccines Report Scope

    Report Attribute Details
    Market size in 2019 US$ 191.89 Million
    Market Size by 2027 US$ 627.49 Million
    Global CAGR (2019 - 2027) 16.3%
    Historical Data 2017-2018
    Forecast period 2020-2027
    Segments Covered By 技术
    • 树突状细胞癌症疫苗
    • 重组癌症疫苗
    • 抗原癌症疫苗
    • 全细胞癌症疫苗
    • 病毒载体癌症疫苗
    By 类型
    • 预防性癌症疫苗
    • 治疗性癌症疫苗
    By 适应症
    • 宫颈癌
    • 前列腺癌
    • 其他适应症
    By 最终用户
    • 儿科
    • 成人
    Regions and Countries Covered 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区
    Market leaders and key company profiles
  • AstraZeneca
  • GlaxoSmithKline plc.
  • Aduro Biotech Inc
  • Pfizer Inc.
  • Sanofi
  • Bristol-Myers Squibb
  • Moderna, Inc.
  • OncBioMune Pharmaceuticals Inc.
  • MaxiVAX
  • Nouscom
  • Get more information on this report

    South and Central America Cancer Vaccines Regional Insights

    The regional scope of South and Central America Cancer Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-cancer-vaccines-market-geography.webp
    Get more information on this report

The List of Companies - South and Central America Cancer Vaccines Market

The List of Companies - South and Central America Cancer Vaccines Market

  1. AstraZeneca
  2. GlaxoSmithKline plc.
  3. Aduro Biotech Inc
  4. Pfizer Inc.
  5. Sanofi
  6. Bristol-Myers Squibb
  7. Moderna, Inc.
  8. OncBioMune Pharmaceuticals Inc.
  9. MaxiVAX
  10. Nouscom
Frequently Asked Questions
How big is the South and Central America Cancer Vaccines Market?

The South and Central America Cancer Vaccines Market is valued at US$ 191.89 Million in 2019, it is projected to reach US$ 627.49 Million by 2027.

What is the CAGR for South and Central America Cancer Vaccines Market by (2019 - 2027)?

As per our report South and Central America Cancer Vaccines Market, the market size is valued at US$ 191.89 Million in 2019, projecting it to reach US$ 627.49 Million by 2027. This translates to a CAGR of approximately 16.3% during the forecast period.

What segments are covered in this report?

The South and Central America Cancer Vaccines Market report typically cover these key segments-

  • 技术 (树突状细胞癌症疫苗, 重组癌症疫苗, 抗原癌症疫苗, 全细胞癌症疫苗, 病毒载体癌症疫苗)
  • 类型 (预防性癌症疫苗, 治疗性癌症疫苗)
  • 适应症 (宫颈癌, 前列腺癌, 其他适应症)
  • What is the historic period, base year, and forecast period taken for South and Central America Cancer Vaccines Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Cancer Vaccines Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in South and Central America Cancer Vaccines Market?

    The South and Central America Cancer Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • AstraZeneca
  • GlaxoSmithKline plc.
  • Aduro Biotech Inc
  • Pfizer Inc.
  • Sanofi
  • Bristol-Myers Squibb
  • Moderna, Inc.
  • OncBioMune Pharmaceuticals Inc.
  • MaxiVAX
  • Nouscom
  • Who should buy this report?

    The South and Central America Cancer Vaccines Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South and Central America Cancer Vaccines Market value chain can benefit from the information contained in a comprehensive market report.